Ustekinumab |
C-340; CNTO-1275 |
Approved |
Johnson & Johnson Innovative Medicine |
Stelara, 喜达诺 |
United States |
Plaque psoriasis |
Janssen Biotech Inc |
2009-09-25 |
Multiple Sclerosis; Plaque psoriasis; Dermatitis, Atopic; Crohn Disease; Hidradenitis Suppurativa; Common Variable Immunodeficiency; Uveitis; Colitis, Ulcerative; Arthritis, Psoriatic; Takayasu Arteritis; Lupus Erythematosus, Systemic; Psoriasis; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Sjogren's Syndrome; Spondylitis, Ankylosing; Pouchitis; Ichthyosis; Dermatomyositis; Inflammatory Bowel Diseases; Type I Leukocyte Adhesion Defect; Polymyositis; Liver Cirrhosis, Biliary |
Details
|
Ustekinumab biosimilar(Formycon) |
FYB-202 |
Approved |
Formycon AG |
OTULFI |
EU |
Crohn Disease; Colitis, Ulcerative |
Fresenius Kabi Deutschland Gmbh, Formycon AG |
2024-09-25 |
Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab Biosimilar (qyuns) |
QX-001S; QX-001-S; HDM-3001 |
Approved |
Qyuns Therapeutics Co Ltd |
|
Mainland China |
Plaque psoriasis |
Qyuns Therapeutics Co Ltd |
2024-10-29 |
Psoriasis; Plaque psoriasis |
Details
|
Ustekinumab Biosimilar(Celltrion) |
CT-P43 |
Approved |
Celltrion Inc |
Steqeyma, Steqeyma IV |
Canada |
Plaque psoriasis; Arthritis, Psoriatic; Crohn Disease |
Celltrion Inc |
2024-08-01 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab biosimilar (Biocon) |
|
Approved |
Biocon Biologics Ltd |
Bmab 1200, Yesintek |
United States |
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease |
Biocon Biologics Inc |
2024-11-29 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis |
Details
|
Ustekinumab biosimilar (Alvotech) |
AVT04; AVT-04 |
Approved |
Alvotech hf |
Jamteki, Uzpruvo, SELARSDI™, JamtekiTM, Ustekinumab BS (F) |
Japan |
Arthritis, Psoriatic; Psoriasis |
Fuji Pharma Co Ltd |
2023-09-25 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab biosimilar(Amgen) |
ABP-654 |
Approved |
Amgen Inc |
Wezlana, WEZLANA, wezenla |
United States |
Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis |
Amgen Inc |
2023-10-31 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis |
Details
|
Ustekinumab biosimilar(DM Bio) |
DA-3115; DMB-3115 |
Approved |
Dong-A Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd |
IMULDOSA, Absimky |
United States |
Psoriasis |
Dong-A ST Co Ltd, Meiji Seika Kaisha Ltd |
2024-10-11 |
Psoriasis; Colitis, Ulcerative; Crohn Disease |
Details
|
Ustekinumab |
C-340; CNTO-1275 |
Approved |
Johnson & Johnson Innovative Medicine |
Stelara, 喜达诺 |
United States |
Plaque psoriasis |
Janssen Biotech Inc |
2009-09-25 |
Multiple Sclerosis; Plaque psoriasis; Dermatitis, Atopic; Crohn Disease; Hidradenitis Suppurativa; Common Variable Immunodeficiency; Uveitis; Colitis, Ulcerative; Arthritis, Psoriatic; Takayasu Arteritis; Lupus Erythematosus, Systemic; Psoriasis; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Sjogren's Syndrome; Spondylitis, Ankylosing; Pouchitis; Ichthyosis; Dermatomyositis; Inflammatory Bowel Diseases; Type I Leukocyte Adhesion Defect; Polymyositis; Liver Cirrhosis, Biliary |
Details
|
Ustekinumab biosimilar(Formycon) |
FYB-202 |
Approved |
Formycon AG |
OTULFI |
EU |
Crohn Disease; Colitis, Ulcerative |
Fresenius Kabi Deutschland Gmbh, Formycon AG |
2024-09-25 |
Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab Biosimilar (qyuns) |
QX-001S; QX-001-S; HDM-3001 |
Approved |
Qyuns Therapeutics Co Ltd |
|
Mainland China |
Plaque psoriasis |
Qyuns Therapeutics Co Ltd |
2024-10-29 |
Psoriasis; Plaque psoriasis |
Details
|
Ustekinumab Biosimilar(Celltrion) |
CT-P43 |
Approved |
Celltrion Inc |
Steqeyma, Steqeyma IV |
Canada |
Plaque psoriasis; Arthritis, Psoriatic; Crohn Disease |
Celltrion Inc |
2024-08-01 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab biosimilar (Biocon) |
|
Approved |
Biocon Biologics Ltd |
Bmab 1200, Yesintek |
United States |
Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease |
Biocon Biologics Inc |
2024-11-29 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis |
Details
|
Ustekinumab biosimilar (Alvotech) |
AVT04; AVT-04 |
Approved |
Alvotech hf |
Jamteki, Uzpruvo, SELARSDI™, JamtekiTM, Ustekinumab BS (F) |
Japan |
Arthritis, Psoriatic; Psoriasis |
Fuji Pharma Co Ltd |
2023-09-25 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab biosimilar(Amgen) |
ABP-654 |
Approved |
Amgen Inc |
Wezlana, WEZLANA, wezenla |
United States |
Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis |
Amgen Inc |
2023-10-31 |
Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis |
Details
|
Ustekinumab biosimilar(DM Bio) |
DA-3115; DMB-3115 |
Approved |
Dong-A Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd |
IMULDOSA, Absimky |
United States |
Psoriasis |
Dong-A ST Co Ltd, Meiji Seika Kaisha Ltd |
2024-10-11 |
Psoriasis; Colitis, Ulcerative; Crohn Disease |
Details
|